177 related articles for article (PubMed ID: 12003966)
1. In vitro susceptibilities of Zygomycota to polyenes.
Dannaoui E; Meis JF; Mouton JW; Verweij PE;
J Antimicrob Chemother; 2002 May; 49(5):741-4. PubMed ID: 12003966
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different media.
Vitale RG; Meis JF; Mouton JW; Verweij PE
J Antimicrob Chemother; 2003 Jul; 52(1):65-70. PubMed ID: 12775672
[TBL] [Abstract][Full Text] [Related]
3. Overview of SPA-S-843 in vitro activity against filamentous fungi.
Rimaroli C; Bruzzese T
Chemotherapy; 2000; 46(1):28-35. PubMed ID: 10601795
[TBL] [Abstract][Full Text] [Related]
4. Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.
Johnson EM; Ojwang JO; Szekely A; Wallace TL; Warnock DW
Antimicrob Agents Chemother; 1998 Jun; 42(6):1412-6. PubMed ID: 9624486
[TBL] [Abstract][Full Text] [Related]
5. Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species.
Shu M; Ellepola AN; Samaranayake LP
J Clin Microbiol; 2001 Jul; 39(7):2732-5. PubMed ID: 11427609
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method.
Singh J; Rimek D; Kappe R
Mycoses; 2005 Jul; 48(4):246-50. PubMed ID: 15982206
[TBL] [Abstract][Full Text] [Related]
7. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
González GM
Med Mycol; 2009 Feb; 47(1):71-6. PubMed ID: 19101837
[TBL] [Abstract][Full Text] [Related]
9. Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Alastruey-Izquierdo A; Castelli MV; Cuesta I; Monzon A; Cuenca-Estrella M; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2009 Apr; 53(4):1686-9. PubMed ID: 19171801
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Gómez-López A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
J Antimicrob Chemother; 2001 Dec; 48(6):919-21. PubMed ID: 11733480
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Johnson EM; Szekely A; Warnock DW
J Antimicrob Chemother; 1998 Dec; 42(6):741-5. PubMed ID: 10052897
[TBL] [Abstract][Full Text] [Related]
12. [Possible use of a single test culture in determining the biological activity of polyene antibiotics].
Fradkova TA
Antibiotiki; 1979 Jan; 24(1):55-60. PubMed ID: 570822
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
[TBL] [Abstract][Full Text] [Related]
14. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.
Hapala I; Klobucníková V; Mazánová K; Kohút P
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1206-9. PubMed ID: 16246082
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of zygomycetes to conventional and new antifungals.
Dannaoui E; Meletiadis J; Mouton JW; Meis JF; Verweij PE;
J Antimicrob Chemother; 2003 Jan; 51(1):45-52. PubMed ID: 12493786
[TBL] [Abstract][Full Text] [Related]
16. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
17. Anti-Rhodotorula activity of mycophenolic acid enhanced in the presence of polyene antibiotic nystatin.
Kinoshita H; Wongsuntornpoj S; Ihara F; Nihira T
Lett Appl Microbiol; 2017 Feb; 64(2):144-149. PubMed ID: 27801509
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
[TBL] [Abstract][Full Text] [Related]
20. [The sensitivity of yeasts from the Candida genus isolated from cancer patients to polyene antifungals].
Alves SH; Cury AE
Rev Inst Med Trop Sao Paulo; 1992; 34(3):251-4. PubMed ID: 1342079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
